Form 8-K - Current report:
SEC Accession No. 0001628280-24-049241
Filing Date
2024-11-26
Accepted
2024-11-26 12:55:47
Documents
17
Period of Report
2024-11-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jan-20241119.htm   iXBRL 8-K 27953
2 EX-10.118 exh10118_alyea-soinbioxter.htm EX-10.118 35571
6 image_0.jpg GRAPHIC 10972
7 image_1.jpg GRAPHIC 38512
8 image_2.jpg GRAPHIC 32352
  Complete submission text file 0001628280-24-049241.txt   315861

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20241119.xsd EX-101.SCH 1810
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20241119_lab.xml EX-101.LAB 23913
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20241119_pre.xml EX-101.PRE 13664
19 EXTRACTED XBRL INSTANCE DOCUMENT jan-20241119_htm.xml XML 2968
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 241501147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)